On September 24th, we join the global community in recognizing World Cancer Research Day (WCRD)—an international movement dedicated to highlighting the critical role of cancer research in driving breakthroughs for cancer control and treatment.
This year WCRD focuses on the importance of innovation under the motto “Innovation In Cancer Research Drives Progress Toward Health Equity”. Innovation is essential across the whole cancer research continuum from prevention and screening to early detection, diagnosis or treatment.
One of the most exciting and promising fields in cancer research is the study of the human microbiome—the trillions of microorganisms living in and on our bodies—and its potential to transform cancer therapies. Recent research has revealed how manipulating the microbiome can boost the effectiveness of treatments like chemotherapy and immunotherapy, paving the way for personalized, more effective cancer therapies.
The progress being made in microbiome research offers a new frontier of hope, bringing us closer to tailored treatments that enhance patients’ responses to cancer therapies. That is why at Microviable Therapeutics we investigate the relationship between microbiota and cancer, with the firm intention of developing new drugs to help prevent and treat this complex disease.
Let’s continue to support the incredible efforts of researchers worldwide who are pushing the boundaries of cancer treatment.
